Your browser doesn't support javascript.
loading
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
Vetter, Marcus; Landin, Julia; Szczerba, Barbara Maria; Castro-Giner, Francesc; Gkountela, Sofia; Donato, Cinzia; Krol, Ilona; Scherrer, Ramona; Balmelli, Catharina; Malinovska, Alexandra; Zippelius, Alfred; Kurzeder, Christian; Heinzelmann-Schwarz, Viola; Weber, Walter Paul; Rochlitz, Christoph; Aceto, Nicola.
Afiliação
  • Vetter M; Gynecologic Cancer Center, University Hospital Basel, 4056, Basel, Switzerland.
  • Landin J; Department of Medical Oncology, University Hospital Basel, 4056, Basel, Switzerland.
  • Szczerba BM; Department of Medical Oncology, University Hospital Basel, 4056, Basel, Switzerland.
  • Castro-Giner F; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Gkountela S; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Donato C; SIB Swiss Institute of Bioinformatics, 1015, Lausanne, Switzerland.
  • Krol I; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Scherrer R; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Balmelli C; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Malinovska A; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Mattenstrasse 28, CH-4058, Basel, Switzerland.
  • Zippelius A; Department of Medical Oncology, University Hospital Basel, 4056, Basel, Switzerland.
  • Kurzeder C; Department of Medical Oncology, University Hospital Basel, 4056, Basel, Switzerland.
  • Heinzelmann-Schwarz V; Department of Medical Oncology, University Hospital Basel, 4056, Basel, Switzerland.
  • Weber WP; Gynecologic Cancer Center, University Hospital Basel, 4056, Basel, Switzerland.
  • Rochlitz C; Breast Center, University Hospital Basel, 4056, Basel, Switzerland.
  • Aceto N; Gynecologic Cancer Center, University Hospital Basel, 4056, Basel, Switzerland.
Breast Cancer Res ; 20(1): 141, 2018 11 20.
Article em En | MEDLINE | ID: mdl-30458879
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Eritrócitos / Denosumab / Células Neoplásicas Circulantes / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Eritrócitos / Denosumab / Células Neoplásicas Circulantes / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça